These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Synthetic deoxynojirimycin derivatives bearing a thiolated, fluorinated or unsaturated N-alkyl chain: identification of potent α-glucosidase and trehalase inhibitors as well as F508del-CFTR correctors. Cendret V; Legigan T; Mingot A; Thibaudeau S; Adachi I; Forcella M; Parenti P; Bertrand J; Becq F; Norez C; Désiré J; Kato A; Blériot Y Org Biomol Chem; 2015 Nov; 13(43):10734-44. PubMed ID: 26356422 [TBL] [Abstract][Full Text] [Related]
10. An overview of therapeutic potential of N-alkylated 1-deoxynojirimycin congeners. Iftikhar M; Lu Y; Zhou M Carbohydr Res; 2021 Jun; 504():108317. PubMed ID: 33932806 [TBL] [Abstract][Full Text] [Related]
11. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin. Luan Z; Higaki K; Aguilar-Moncayo M; Ninomiya H; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y Chembiochem; 2009 Nov; 10(17):2780-92. PubMed ID: 19830760 [TBL] [Abstract][Full Text] [Related]
12. Alpha-1-C-alkyl-1-deoxynojirimycin derivatives as potent and selective inhibitors of intestinal isomaltase: remarkable effect of the alkyl chain length on glycosidase inhibitory profile. Godin G; Compain P; Martin OR; Ikeda K; Yu L; Asano N Bioorg Med Chem Lett; 2004 Dec; 14(24):5991-5. PubMed ID: 15546715 [TBL] [Abstract][Full Text] [Related]
13. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases. Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160 [TBL] [Abstract][Full Text] [Related]
14. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus. Durantel D; Branza-Nichita N; Carrouée-Durantel S; Butters TD; Dwek RA; Zitzmann N J Virol; 2001 Oct; 75(19):8987-98. PubMed ID: 11533162 [TBL] [Abstract][Full Text] [Related]
15. Biological study of the angiogenesis inhibitor N-(8-(3-ethynylphenoxy)octyl-1-deoxynojirimycin. Zhao Y; Zhou Y; O' Boyle KM; Murphy PV Chem Biol Drug Des; 2010 Jun; 75(6):570-7. PubMed ID: 20565474 [TBL] [Abstract][Full Text] [Related]
17. Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis. Mellor HR; Neville DC; Harvey DJ; Platt FM; Dwek RA; Butters TD Biochem J; 2004 Aug; 381(Pt 3):861-6. PubMed ID: 15128268 [TBL] [Abstract][Full Text] [Related]
18. Structures and activity of cellulase inhibitors enzymatically synthesized from cellooligosaccharides and 1-deoxynojirimycin. Kawaguchi T; Sugimoto K; Hayashi H; Arai M Biosci Biotechnol Biochem; 1996 Feb; 60(2):344-6. PubMed ID: 9063987 [TBL] [Abstract][Full Text] [Related]
19. Purification and identification of 1-deoxynojirimycin (DNJ) in okara fermented by Bacillus subtilis B2 from Chinese traditional food (Meitaoza). Zhu YP; Yamaki K; Yoshihashi T; Ohnishi Kameyama M; Li XT; Cheng YQ; Mori Y; Li LT J Agric Food Chem; 2010 Apr; 58(7):4097-103. PubMed ID: 20196601 [TBL] [Abstract][Full Text] [Related]
20. Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery. Erlanson DA; Arndt JW; Cancilla MT; Cao K; Elling RA; English N; Friedman J; Hansen SK; Hession C; Joseph I; Kumaravel G; Lee WC; Lind KE; McDowell RS; Miatkowski K; Nguyen C; Nguyen TB; Park S; Pathan N; Penny DM; Romanowski MJ; Scott D; Silvian L; Simmons RL; Tangonan BT; Yang W; Sun L Bioorg Med Chem Lett; 2011 May; 21(10):3078-83. PubMed ID: 21459573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]